News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Easom Eric
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/15/2023 |
4
| Easom Eric (CEO) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $5.377, valued at
$53.8k
|
|
| 02/24/2023 |
4
| Easom Eric (CEO) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Granted 267,650 options to buy
@ $11.99, valued at
$3.2M
|
|
| 11/14/2022 |
4
| Easom Eric (CEO) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Sold 4,413 shares
@ $15.3248, valued at
$67.6k
Sold 23 shares
@ $15.04, valued at
$345.9 |
|
| 11/07/2022 |
4
| Easom Eric (CEO) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Sold 11,082 shares
@ $15.6725, valued at
$173.7k
Sold 3,083 shares
@ $16.0155, valued at
$49.4k
Sold 8,828 shares
@ $15.7991, valued at
$139.5k
Sold 10,167 shares
@ $15.9049, valued at
$161.7k
Sold 2,036 shares
@ $16.7171, valued at
$34k
|
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Easom Eric (CEO) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Converted 4,907 shares
@ $0
Converted 4,907 convertible preferred
@ $0 |
|
| 03/24/2022 |
3
| Easom Eric (CEO) has filed a Form 3 on AN2 Therapeutics, Inc. |
|
|